ASCO meeting recap -- prospects for a reversal?

Analyzing Pfizer, GSK, BMS, Janssen, AstraZeneca, Mirati, Amgen, and others...

The bio sector is seeing some life with improved fundamentals, which could be an early sign of reversal.  ASCO in Chicago is wrapping up and data presented this past weekend has been a nice change from the flurry of failures that has plagued the space in recent times. There were several positive updates presented at ASCO, with Enhertu taking over the sp…